Since spring 2018, the Robert Koch Institute has also defined the counties of Munich, Starnberg and Weilheim-Schongau as TBE risk areas.
At a manageable risk:
– in the disctict Munich, 343 000 inhabitants, there have been 4 FSME cases (= 0.4 / year) since 2008
– in the district Starnberg, 134 000 inhabitants, there have been 9 TBE cases (= 0.6 / year) since 2003
– in the district Weilheim-Schongau, 134 000 inhabitants, there were 3 TBE cases since 2007 (including one vaccinated person, so probably vaccine antibodies were measured) = 0.3 / year.
Only 52% of the reported illnesses reported a classic TBE disease (meningitis, encephalitis). In these three districts there is only every 3 – 6 years a serious TBE case – almost exclusively in over 40-year-old adults.
Nevertheless, the RKI recommends the TBE vaccination for anyone living in a “risk area”. The side effects of the vaccine or the risk-benefit assessment are completely ignored:
Although TBE vaccines play a minor role within Germany, they occupy with 13 percent a leading position in all potential adverse drug reactions. From 2001 to 2017, 4317 potential adverse events were reported, including 72 “permanent injuries” and more than 1100 complaints “unrecovered” at the time of reporting – including severe neurological conditions such as paralysis, encephalitis, seizures or multiple sclerosis.
There were 1208 reports concerning seizures, coordination disorders, nerve paralysis, meningitis and encephalitis. 13 deaths were reported, including paralysis and heart failure.